Nectar Lifesciences Limited (NECLIFE.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.96B |
| Enterprise Value | 840.01M |
| P/E Ratio | -0.84 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0.76 |
| Price/Book Ratio | 0.39 |
| Enterprise/Revenue | 0.37 |
| Enterprise/EBITDA | -4.08 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -1.02 |
| Operating Margin | -0.48 |
AD
Management Effectiveness
| Return On Assets | -0.47 |
| Return On Equity | -0.39 |
Income Statement
| Revenue | 20.11M |
| Revenue/Share | 14.31 |
| Gross Profit | -590.34M |
| EBITDA | -289.51M |
| Net Income | -2.93B |
| Diluted EPS | -14.57 |
Balance Sheet
| Total Cash | 1.25B |
| Total Cash/Share | 6.23 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 8.4 |
| Book Value Per Share | 28.98 |
Price History
| 52-Week Change | -40.63 |
| 52-Week High | 22.4 |
| 52-Week Low | 9.3 |
| Moving Average 50 Days | 12.04 |
| Moving Average 200 Days | 13.88 |
Statistics
| Average Volume | 286,379 |
| Shares Outstanding | 194.26M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 10:1 |
| Last Split Date | November 12, 2008 |
AD
